Novartis 2003 Annual Report Cover Financial Highlights News in 2003 Letter from Daniel Vasella Pharmaceuticals Consumer Health Corporate Citizenship Health, Safety and Environment Human Resources Corporate Governance Board of Directors Executive Committee Business Unit Heads Operating and Financial Review Equity Strategy and Share Information Group Consolidated Financial Statements and Notes Principal Companies Reconciliation to US GAAP Financial Statements of Novartis AG Due Dates for Reporting in 2004 Contacts Back Cover